Frequency of Rearrangements Versus Small Indels Mutations in BRCA1 and BRCA2 Genes in Turkish Patients with High Risk Breast and Ovarian Cancer
Yıl: 2018 Cilt: 14 Sayı: 2 Sayfa Aralığı: 93 - 100 Metin Dili: İngilizce DOI: 10.5152/ejbh.2017.3799 İndeks Tarihi: 09-01-2019
Frequency of Rearrangements Versus Small Indels Mutations in BRCA1 and BRCA2 Genes in Turkish Patients with High Risk Breast and Ovarian Cancer
Öz: Objective: The current rearrangement ratio of BRCA1 and BRCA2 genes is not known in the Turkish population. Rearrangements are not routinelyinvestigated in many Turkish laboratories. This creates problems and contradictions between clinics. Therefore, the aim of this study was toevaluate the distribution and frequency of rearrangements in BRCA1 and BRCA2 genes in high-risk families and to clarify the limits of BRCA1 andBRCA2 testing in Turkey.Materials and Methods: The study included 1809 patients at high risk of breast cancer or ovarian cancer. All patients were investigated for bothsmall indels and rearrangements of BRCA genes using DNA sequencing and multiplex ligation-dependent probe amplification (MLPA) analysis.Results: The overall frequency of rearrangements was 2% (25/1262). The frequency of rearrangements was 1.7% (18/1086) and 4% (9/206) inpatients with breast cancer and ovarian cancer, respectively. The frequency of rearrangements was 3.7% (8/215) in patients with triple-negative breastcancer. The rearrangement rate was 7.7% (2/26) in patients with both breast and ovarian cancer.Conclusions: Rearrangements were found with high rates and were strongly associated with bilateral and triple-negative status of patients withbreast cancer, which are signs of high risk for breast and ovarian cancer. Analysis of rearrangements should definitely be included in routine clinicalpractice in Turkey for high-risk families and also for improved cancer risk prediction for families.
Anahtar Kelime: Konular:
Belge Türü: Makale Makale Türü: Araştırma Makalesi Erişim Türü: Erişime Açık
- Timoteo AR, Albuquerque BM, Moura PC, Ramos CC, Agnez-Lima LF, Walsh T, King MC, Lajus TB. Identification of a new BRCA2 large genomic deletion associated with high risk male breast cancer. Hered Cancer Clin Pract 2015; 13: 2. (PMID: 25632310)[CrossRef ]
- Falchetti M, Lupi R, Rizzolo P, Ceccarelli K, Zanna I, Calò V, Tommasi S, Masala G, Paradiso A, Gulino A, Giannini G, Russo A, Palli D, Ottini L. BRCA1/BRCA2 rearrangements and CHEK2 common mutations are infrequent in Italian male breast cancer cases. Breast Cancer Res Treat 2008; 110: 161-167. (PMID: 17661168) [CrossRef ]
- Sluiter MD, van Rensburg EJ. Large genomic rearrangements of the BRCA1 and BRCA2 genes: review of the literature and report of a novel BRCA1 mutation. Breast Cancer Res Treat 2011; 125: 325-349. (PMID: 20232141) [CrossRef ]
- Richards CS, Bale S, Bellissimo DB, Das S, Grody WW, Hegde MR, Lyon E, Ward BE; Molecular Subcommittee of the ACMG Laboratory Quality Assurance Committee. Molecular Subcommittee of the ALQAC: ACMG recommendations for standards for interpretation and reporting of sequence variations: Revisions 2007. Genet Med 2008; 10: 294-300. (PMID: 18414213) [CrossRef ]
- Hendrickson BC, Judkins T, Ward BD, Eliason K, Deffenbaugh AE, Burbidge LA, Pyne K, Leclair B, Ward BE, Scholl T. Prevalence of five previously reported and recurrent BRCA1 genetic rearrangement mutations in 20,000 patients from hereditary breast/ovarian cancer families. Genes Chromosomes Cancer 2005; 43: 309-313. (PMID: 15846789) [CrossRef ]
- Walsh T, Casadei S, Coats KH, Swisher E, Stray SM, Higgins J, Roach KC, Mandell J, Lee MK, Ciernikova S, Foretova L, Soucek P, King MC. Spectrum of mutations in BRCA1, BRCA2, CHEK2, and TP53 in families at high risk of breast cancer. JAMA 2006; 295: 1379-1388. (PMID: 16551709) [CrossRef ]
- Ewald IP, Ribeiro PL, Palmero EI, Cossio SL, Giugliani R, Ashton-Prolla P. Genomic rearrangements in BRCA1 and BRCA2: A literature review. Genet Mol Biol 2009; 32: 437-446. (PMID: 21637503) [CrossRef ]
- Arnold AG, Otegbeye E, Fleischut MH, Glogowski EA, Siegel B, Boyar SR, Salo-Mullen E, Amoroso K, Sheehan M, Berliner JL, Stadler ZK, Kauff ND, Offit K, Robson ME, Zhang L. Assessment of individuals with BRCA1 and BRCA2 large rearrangements in high-risk breast and ovarian cancer families. Breast Cancer Res Treat 2014; 145: 625-634. (PMID: 24825132) [CrossRef ]
- Aydin F, Akagun T, Yildiz B, Fidan E, Ozdemir F, Kavgaci H. Clinicopathologic characteristics and BRCA-1/BRCA-2 mutations of Turkish patients with breast cancer. Bratisl Lek Listy 2011; 112: 521-523. (PMID: 21954532)
- Manguoğlu E, Güran S, Yamaç D, Colak T, Simşek M, Baykara M, Akaydın M, Lüleci G. Germline mutations of BRCA1 and BRCA2 genes in Turkish breast, ovarian, and prostate cancer patients. Cancer Genet Cytogenet 2010; 203: 230-237. (PMID: 21156238) [CrossRef ]
- Kwong A, Chen J, Shin VY, Ho JC, Law FB, Au CH, Chan TL, Ma ES, Ford JM. The importance of analysis of long-range rearrangement of BRCA1 and BRCA2 in genetic diagnosis of familial breast cancer. Cancer Genet 2015; 208: 448-454. (PMID: 26271414) [CrossRef ]
- Pylkas K, Erkko H, Nikkila J, Solyom S, Winqvist R. Analysis of large deletions in BRCA1, BRCA2 and PALB2 genes in Finnish breast and ovarian cancer families. BMC Cancer 2008; 8: 146. (PMID: 18501021) [CrossRef ]
- Casilli F, Tournier I, Sinilnikova OM, Coulet F, Soubrier F, Houdayer C, Hardouin A, Berthet P, Sobol H, Bourdon V, Muller D, Fricker JP, Capoulade-Metay C, Chompret A, Nogues C, Mazoyer S, Chappuis P, Maillet P, Philippe C, Lortholary A, Gesta P, Bézieau S, Toulas C, Gladieff L, Maugard CM, Provencher DM, Dugast C, Delvincourt C, Nguyen TD, Faivre L, Bonadona V, Frébourg T, Lidereau R, Stoppa-Lyonnet D, Tosi M. The contribution of germline rearrangements to the spectrum of BRCA2 mutations. J Med Genet 2006; 43: e49. (PMID: 16950820) [CrossRef ]
- Gonzalez-Hormazabal P, Gutierrez-Enriquez S, Gaete D, Reyes JM, Peralta O, Waugh E, Gomez F, Margarit S, Bravo T, Blanco R, Diez O, Jara L. Spectrum of BRCA1/2 point mutations and genomic rearrangements in high-risk breast/ovarian cancer Chilean families. Breast Cancer Res Treat 2011; 126: 705-716. (PMID: 20859677) [CrossRef ]
- Seong MW, Cho SI, Kim KH, Chung IY, Kang E, Lee JW, Park SK, Lee MH, Choi DH, Yom CK, Noh WC, Chang MC, Park SS, Kim SW; Korean Hereditary Breast Cancer Study Group. A multi-institutional study of the prevalence of BRCA1 and BRCA2 large genomic rearrangements in familial breast cancer patients. BMC Cancer 2014; 14: 645. (PMID: 25176351) [CrossRef ]
- De Silva S, Tennekoon KH, Karunanayake EH, Amarasinghe I, Angunawela P. Analysis of BRCA1and BRCA2 large genomic rearrangements in Sri Lankan familial breast cancer patients and at risk individuals. BMC Res Notes 2014; 7: 344. (PMID: 24906410) [CrossRef ]
- Palma MD, Lombardi G, Donach ME, Borgato L, Zustovich F, Furini L, Nicoletto MO. Tolerability of PLD/oxaliplatin regimen in recurrent ovarian cancer patients with previous fragility to carboplatin/paclitaxel treatment. Am J Clin Oncol 2011; 34: 305-308. (PMID: 20622643) [CrossRef ]
- Gutiérrez-Enríquez S, de la Hoya M, Martínez-Bouzas C, Sanchez de Abajo A, Ramón y Cajal T, Llort G, Blanco I, Beristain E, Díaz-Rubio E, Alonso C, Tejada MI, Caldés T, Diez O. Screening for large rearrangements of the BRCA2 gene in Spanish families with breast/ovarian cancer. Breast Cancer Res Treat 2007; 103: 103-107. (PMID: 17063271) [CrossRef ]
- James PA, Sawyer S, Boyle S, Young MA, Kovalenko S, Doherty R, McKinley J, Alsop K, Beshay V, Harris M, Fox S, Lindeman GJ, Mitchell G. Large genomic rearrangements in the familial breast and ovarian cancer gene BRCA1 are associated with an increased frequency of high risk features. Fam Cancer 2015; 14: 287-295. (PMID: 25678442) [CrossRef ]
- Vasickova P, Machackova E, Lukesova M, Damborsky J, Horky O, Pavlu H, Kuklova J, Kosinova V, Navratilova M, Foretova L. High occurrence of BRCA1 intragenic rearrangements in hereditary breast and ovarian cancer syndrome in the Czech Republic. BMC Med Genet 2007; 8: 32. (PMID: 17561994) [CrossRef ]
- Aktas D, Gultekin M, Kabacam S, Alikasifoglu M, Turan AT, Tulunay G, Kose MF, Ortac F, Yüce K, Tunçbilek E, Ayhan A. Identification of point mutations and large rearrangements in the BRCA1 gene in 667 Turkish unselected ovarian cancer patients. Gynecol Oncol 2010; 119: 131-135. (PMID: 20638108) [CrossRef ]
- Celik A, Acar M, Erkul MC, Gunduz E, Gunduz M. Relationship of Breast Cancer with Ovarian Cancer. In: A Concise Review of Molecular Pathology of Breast Cancer. edn.: 187-202.
- Cross L. Population Screening for Hereditary Cancer Syndromes: Opinions from Amazon Mechanical Turks. University of Northern Iowa; 2014.
- Judkins T, Rosenthal E, Arnell C, Burbidge LA, Geary W, Barrus T, Schoenberger J, Trost J, Wenstrup RJ, Roa BB. Clinical significance of large rearrangements in BRCA1 and BRCA2. Cancer 2012; 118: 5210- 5216. (PMID: 22544547) [CrossRef ]
- Ozdag H, Tez M, Sayek I, Müslümanoglu M, Tarcan O, Içli F, Oztürk M, Ozçelik T. Germ line BRCA1 and BRCA2 gene mutations in Turkish breast cancer patients. Eur J Cancer 2000; 36: 2076-2082. (PMID: 11044644) [CrossRef ]
- Guran S, Ozet A, Dede M, Gille JJ, Yenen MC. Hereditary breast cancer syndromes in a Turkish population. Results of molecular germline analysis. Cancer Genet Cytogenet 2005; 160:164-168. (PMID: 15993273) [CrossRef ]
- Mehrgou A, Akouchekian M. The importance of BRCA1 and BRCA2 genes mutations in breast cancer development. Med J Islam Repub Iran 2016; 30: 369. (PMID: 27493913)
| APA | YAZICI H, KILIÇ S, AKDENİZ ÖDEMİŞ D, ŞÜKRÜOĞLU Ö, TUNCER S, avsar m, KURU TÜRKCAN G, çelik b, KÜÇÜCÜK N, Saip P (2018). Frequency of Rearrangements Versus Small Indels Mutations in BRCA1 and BRCA2 Genes in Turkish Patients with High Risk Breast and Ovarian Cancer. , 93 - 100. 10.5152/ejbh.2017.3799 |
| Chicago | YAZICI HÜLYA,KILIÇ Seda,AKDENİZ ÖDEMİŞ DEMET,ŞÜKRÜOĞLU Özge,TUNCER SEREF BUGRA,avsar mukaddes,KURU TÜRKCAN GÖZDE,çelik betül,KÜÇÜCÜK NEZİHE SEDEN,Saip Pınar Frequency of Rearrangements Versus Small Indels Mutations in BRCA1 and BRCA2 Genes in Turkish Patients with High Risk Breast and Ovarian Cancer. (2018): 93 - 100. 10.5152/ejbh.2017.3799 |
| MLA | YAZICI HÜLYA,KILIÇ Seda,AKDENİZ ÖDEMİŞ DEMET,ŞÜKRÜOĞLU Özge,TUNCER SEREF BUGRA,avsar mukaddes,KURU TÜRKCAN GÖZDE,çelik betül,KÜÇÜCÜK NEZİHE SEDEN,Saip Pınar Frequency of Rearrangements Versus Small Indels Mutations in BRCA1 and BRCA2 Genes in Turkish Patients with High Risk Breast and Ovarian Cancer. , 2018, ss.93 - 100. 10.5152/ejbh.2017.3799 |
| AMA | YAZICI H,KILIÇ S,AKDENİZ ÖDEMİŞ D,ŞÜKRÜOĞLU Ö,TUNCER S,avsar m,KURU TÜRKCAN G,çelik b,KÜÇÜCÜK N,Saip P Frequency of Rearrangements Versus Small Indels Mutations in BRCA1 and BRCA2 Genes in Turkish Patients with High Risk Breast and Ovarian Cancer. . 2018; 93 - 100. 10.5152/ejbh.2017.3799 |
| Vancouver | YAZICI H,KILIÇ S,AKDENİZ ÖDEMİŞ D,ŞÜKRÜOĞLU Ö,TUNCER S,avsar m,KURU TÜRKCAN G,çelik b,KÜÇÜCÜK N,Saip P Frequency of Rearrangements Versus Small Indels Mutations in BRCA1 and BRCA2 Genes in Turkish Patients with High Risk Breast and Ovarian Cancer. . 2018; 93 - 100. 10.5152/ejbh.2017.3799 |
| IEEE | YAZICI H,KILIÇ S,AKDENİZ ÖDEMİŞ D,ŞÜKRÜOĞLU Ö,TUNCER S,avsar m,KURU TÜRKCAN G,çelik b,KÜÇÜCÜK N,Saip P "Frequency of Rearrangements Versus Small Indels Mutations in BRCA1 and BRCA2 Genes in Turkish Patients with High Risk Breast and Ovarian Cancer." , ss.93 - 100, 2018. 10.5152/ejbh.2017.3799 |
| ISNAD | YAZICI, HÜLYA vd. "Frequency of Rearrangements Versus Small Indels Mutations in BRCA1 and BRCA2 Genes in Turkish Patients with High Risk Breast and Ovarian Cancer". (2018), 93-100. https://doi.org/10.5152/ejbh.2017.3799 |
| APA | YAZICI H, KILIÇ S, AKDENİZ ÖDEMİŞ D, ŞÜKRÜOĞLU Ö, TUNCER S, avsar m, KURU TÜRKCAN G, çelik b, KÜÇÜCÜK N, Saip P (2018). Frequency of Rearrangements Versus Small Indels Mutations in BRCA1 and BRCA2 Genes in Turkish Patients with High Risk Breast and Ovarian Cancer. European Journal of Breast Health, 14(2), 93 - 100. 10.5152/ejbh.2017.3799 |
| Chicago | YAZICI HÜLYA,KILIÇ Seda,AKDENİZ ÖDEMİŞ DEMET,ŞÜKRÜOĞLU Özge,TUNCER SEREF BUGRA,avsar mukaddes,KURU TÜRKCAN GÖZDE,çelik betül,KÜÇÜCÜK NEZİHE SEDEN,Saip Pınar Frequency of Rearrangements Versus Small Indels Mutations in BRCA1 and BRCA2 Genes in Turkish Patients with High Risk Breast and Ovarian Cancer. European Journal of Breast Health 14, no.2 (2018): 93 - 100. 10.5152/ejbh.2017.3799 |
| MLA | YAZICI HÜLYA,KILIÇ Seda,AKDENİZ ÖDEMİŞ DEMET,ŞÜKRÜOĞLU Özge,TUNCER SEREF BUGRA,avsar mukaddes,KURU TÜRKCAN GÖZDE,çelik betül,KÜÇÜCÜK NEZİHE SEDEN,Saip Pınar Frequency of Rearrangements Versus Small Indels Mutations in BRCA1 and BRCA2 Genes in Turkish Patients with High Risk Breast and Ovarian Cancer. European Journal of Breast Health, vol.14, no.2, 2018, ss.93 - 100. 10.5152/ejbh.2017.3799 |
| AMA | YAZICI H,KILIÇ S,AKDENİZ ÖDEMİŞ D,ŞÜKRÜOĞLU Ö,TUNCER S,avsar m,KURU TÜRKCAN G,çelik b,KÜÇÜCÜK N,Saip P Frequency of Rearrangements Versus Small Indels Mutations in BRCA1 and BRCA2 Genes in Turkish Patients with High Risk Breast and Ovarian Cancer. European Journal of Breast Health. 2018; 14(2): 93 - 100. 10.5152/ejbh.2017.3799 |
| Vancouver | YAZICI H,KILIÇ S,AKDENİZ ÖDEMİŞ D,ŞÜKRÜOĞLU Ö,TUNCER S,avsar m,KURU TÜRKCAN G,çelik b,KÜÇÜCÜK N,Saip P Frequency of Rearrangements Versus Small Indels Mutations in BRCA1 and BRCA2 Genes in Turkish Patients with High Risk Breast and Ovarian Cancer. European Journal of Breast Health. 2018; 14(2): 93 - 100. 10.5152/ejbh.2017.3799 |
| IEEE | YAZICI H,KILIÇ S,AKDENİZ ÖDEMİŞ D,ŞÜKRÜOĞLU Ö,TUNCER S,avsar m,KURU TÜRKCAN G,çelik b,KÜÇÜCÜK N,Saip P "Frequency of Rearrangements Versus Small Indels Mutations in BRCA1 and BRCA2 Genes in Turkish Patients with High Risk Breast and Ovarian Cancer." European Journal of Breast Health, 14, ss.93 - 100, 2018. 10.5152/ejbh.2017.3799 |
| ISNAD | YAZICI, HÜLYA vd. "Frequency of Rearrangements Versus Small Indels Mutations in BRCA1 and BRCA2 Genes in Turkish Patients with High Risk Breast and Ovarian Cancer". European Journal of Breast Health 14/2 (2018), 93-100. https://doi.org/10.5152/ejbh.2017.3799 |
